M&A Deal Summary

Renaissance Lakewood Acquires DPT Laboratories

On July 5, 2012, Renaissance Lakewood acquired life science company DPT Laboratories

Acquisition Highlights
  • This is Renaissance Lakewood’s 2nd transaction in the Life Science sector.
  • This is Renaissance Lakewood’s 1st transaction in the United States.
  • This is Renaissance Lakewood’s 1st transaction in Texas.

M&A Deal Summary
Date 2012-07-05
Target DPT Laboratories
Sector Life Science
Buyer(s) Renaissance Lakewood
Deal Type Add-on Acquisition

Target

DPT Laboratories

San Antonio, Texas, United States
DPT Laboratories Ltd. is a contract development and manufacturing organization (CDMO) with a specialized focus on semi-solid and liquid dosage forms.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Renaissance Lakewood

Lakewood, New Jersey, United States
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Renaissance Lakewood is a pharmaceutical company that offers contract development and manufacturing, and commercialization of branded and generic prescription products. Renaissance Lakewood was founded in 2010 and is based in Lakewood, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-21 Confab Laboratories

St-Hubert, Quebec, Canada

Confab Laboratories, Inc. is a pharmaceutical development and contract manufacturing organization.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-13 Renaissance Acquisition - Specialty and Generics Business

Quebec, Canada

Renaissance Acquisition - Specialty and Generics Business comprises portfolio of specialty brands and generic products in the dermatology space, as well as a deep pipeline of complex topical generics and brands in active development. The Business has two high-quality manufacturing sites with capabilities and capacity in creams, ointments, aerosols/foams, gels, suspensions, liquids and suppositories that are complementary to Mylan's existing capabilities.

Sell $1.0B
Mergr

Product

Company

Legal